UFPT Stock Analysis: Buy, Sell, or Hold?
UFPT - UFP Technologies Inc
$213.95
-6.99 (-3.16%)
▼
5d:
-7.2%
30d:
+10.26%
90d:
-12.96%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Get Alerted When UFPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: UFPT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: UFPT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$353.72
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$219.63
2.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UFPT is currently trading at $213.95, which is considered slightly high relative to its 30-day fair value range of $193.35 to $216.57. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.3) compared to its historical average (20.4). Remarkably, the market is currently pricing in an annual earnings decline of 3.5% over the next few years. This pessimistic expectation contrasts with the company's recent 1.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, UFPT is in a strong downtrend. Immediate support is located at $173.86, while resistance sits at $234.56. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: UFPT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $324.50 (+51.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UFPT is in a strong downtrend. Immediate support is located at $173.86, while resistance sits at $234.56. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: UFPT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $324.50 (+51.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$193.35 -
$216.57
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.4%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 51.7% below Wall St target ($324.50)
- CAUTION: Recommendation downgraded due to -7.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$193.35 -
$216.57
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$173.86
Resistance Level
$234.56
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.31
Wall Street Target
$324.50
(+51.7%)
Revenue Growth (YoY)
4.1%
Earnings Growth (YoY)
1.4%
Profit Margin
11.3%
Valuation Discount vs History
-3.5% cheaper
PE vs Historical
18.3 vs 20.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.5%
(market-implied from PE analysis)
1-Year Target
$206.46
(-4%)
2-Year Target
$199.24
(-7%)
3-Year Target
$192.26
(-10%)
3-Yr Target (if PE normalizes)
(PE: 18→20)
$214.26
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 12.5%)
$367.68
(+72%)
Base:
(SPY PE: 18.3, Growth: 12.5%)
$304.97
(+43%)
Bear:
(PE: 15.6, Growth: 12.5%)
$259.22
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 25.14 | Current EPS (TTM): $8.79
Bull Case
$323.15
(+51%)
Analyst growth 33.0%, PE expands to 27.7
Base Case
$293.77
(+37%)
Market implied 33.0%, PE stable at 25.1
Bear Case
$150.24
(-30%)
Severe decline -20.0%, PE contracts to 21.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.3 to 20.4
Stabilization Target:
$238.42
(+11.4%)
PE Expansion Potential:
+11.4%
Share & Embed Analysis
Last updated: May 18, 2026 1:29 AM ET
Data refreshes hourly during market hours. Next update: 2:29 AM
Data refreshes hourly during market hours. Next update: 2:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UFPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason Holt
SELL
100 shares
2025-12-10
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
